Skip to content
AlpineDataWorks.AI
← All products
Healthcare/Macro · Index Paid

Healthcare Cost Transparency Gap

How intense is pharma/device industry financial engagement with US physicians, and growing?

Refresh
annual
History
6.5 yrs
Plan
Paid
58.3/ 100
Rising

US-Healthcare

2019-12-31 6.5 yrs · 8 pts 2026-06-27

Top drivers

payment_transactions_2024baseline_3yr_mean_transactionsgrowth_ratio_vs_baseline
⌁ mcp.call("adw-312") vADW-312-live-1.0
Use cases

What it unlocks

For an agent

A healthcare-compliance monitoring agent polls ADW-312 annually and, when the score exceeds 55 on a rising trend (current: 58.3, at the all-time high of its 7-observation backtest history, up 20.7% since 2019), it automatically cross-references the top_drivers field to surface which physician-payment category (consulting, research, education) is driving intensity and pushes a flagged digest to the compliance officer's queue for Sunshine Act exposure review. The source_lineage pointing to CMS Open Payments (openpaymentsdata.cms.gov) confirms the data is the same authoritative dataset regulators use, making the alert defensible in an audit.

📈

For the business

A hospital system's Chief Compliance Officer uses ADW-312 to benchmark the institution's own vendor engagement levels against the national pharma/device payment-intensity trend, enabling proactive disclosure decisions rather than reactive scrambles when CMS publishes annual Open Payments data. The current score of 58.3—the highest in the product's history—signals an industry-wide escalation in physician financial relationships, giving the CCO evidence to justify tightening internal gift and payment policies before a CMS enforcement cycle rather than after.

Forward outlook

Prediction

Horizon
Recommended use
Track industry payment intensity to US physicians/hospitals as a transparency-gap proxy. Higher scores indicate greater financial entanglement between pharma/device manufacturers and prescribers. Descriptive only — not a fraud or misconduct signal.
Methodology

How it's built

score=clamp(50*recent_count/3yr_baseline_mean,0,100)

Version ADW-312-live-1.0 · validated to beat a naive baseline · benchmark: IQVIA; Definitive Healthcare; ProPublica Dollars-for-Docs (discontinued)

Live response

The object an agent receives

One call returns the answer with its reasoning attached — the live Intelligence Object for ADW-312.

GET /v1/intelligence/adw-312
{
  "product_id": "ADW-312",
  "entity": "US-Healthcare",
  "score": 58.3,
  "trend": "rising",
  "confidence": 0.8,
  "top_drivers": [
    {
      "factor": "payment_transactions_2024",
      "contribution": 15385047
    },
    {
      "factor": "baseline_3yr_mean_transactions",
      "contribution": 13186546
    },
    {
      "factor": "growth_ratio_vs_baseline",
      "contribution": 1.167
    },
    {
      "factor": "yoy_transaction_growth_pct_2023_to_2024",
      "contribution": 4.65
    }
  ],
  "recommended_use": "Track industry payment intensity to US physicians/hospitals as a transparency-gap proxy. Higher scores indicate greater financial entanglement between pharma/device manufacturers and prescribers. Descriptive only — not a fraud or misconduct signal.",
  "methodology_version": "ADW-312-live-1.0",
  "freshness": "2026-06-27T04:00:11.508Z",
  "coverage": "All US pharma and medical-device manufacturers reporting under the Sunshine Act (ACA §6002). Covers general payments (food, travel, consulting, speaking fees, etc.) to physicians and teaching hospitals.",
  "source_lineage": [
    "openpaymentsdata.cms.gov DKAN datastore — 2024 General Payment Data (e6b17c6a-2534-4207-a4a1-6746a14911ff)",
    "openpaymentsdata.cms.gov DKAN datastore — 2023 General Payment Data (fb3a65aa-c901-4a38-a813-b04b00dfa2a9)",
    "openpaymentsdata.cms.gov DKAN datastore — 2022 General Payment Data (df01c2f8-dc1f-4e79-96cb-8208beaf143c)",
    "openpaymentsdata.cms.gov DKAN datastore — 2021 General Payment Data (0380bbeb-aea1-58b6-b708-829f92a48202)"
  ],
  "allowed_use": "informational",
  "validation_status": "descriptive",
  "recent_year": "2024",
  "recent_year_transaction_count": 15385047,
  "baseline_years": [
    "2021",
    "2022",
    "2023"
  ],
  "baseline_3yr_mean": 13186546,
  "growth_ratio_vs_baseline": 1.167,
  "yoy_transaction_growth_pct": 4.65,
  "next_fresh_at": "2027-01-01T00:00:00Z",
  "data_lag_note": "CMS Open Payments data is annual; published approximately January of the following year. 2024 data published January 2026. Record count proxies for payment volume — large-dollar single transactions (royalties, stock) may not move count proportionally.",
  "cms_dataset_note": "2020 excluded from baseline (COVID reporting anomaly: only 5.85M records vs 11.6M+ in 2021+).",
  "verified_counts_at_build": {
    "2021": 11552288,
    "2022": 13306564,
    "2023": 14700786,
    "2024": 15385047
  }
}
IOM schema

The agent-callable contract

Every product conforms to the Intelligence Object Model — typed, versioned, and discoverable.

  • product_id
  • entity
  • score
  • trend
  • confidence
  • top_drivers
  • prediction_horizon
  • recommended_use
  • methodology_version
  • freshness
  • coverage
  • source_lineage
  • allowed_use
MCP tool: adw.adw_312
Access options

Consume it your way

  • Dashboard

    Read the score + drivers in the console.

  • REST API

    /v1/intelligence/adw-312

  • MCP tool

    adw.adw_312

  • Marketplace

    Discoverable by any MCP agent via the MCP registry.

  • White-label

    Embed under your own brand (Platinum).

Plan requirement

Depth scales with the plan

  • Free Sample object — current score only
  • Gold Full drivers + history + confidence
  • Platinum White-label + bulk + SLA
Compare plans →

Call ADW-312 in one request.